Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

Euronews Business takes a look at how European and global markets are performing on Tuesday, amid escalating global tariff ...

The Cadillac team set to debut in Formula One next year has at least six names on a list of potential drivers and will decide ...

Novartis said this morning that its pipeline ... said the company at a 'meet management' event running in London today. The raised forecast reflects increases in the sales projections for a ...

Kesimpta Market Report 2025 The Business Research Company's Key Market Driver In Kesimpta Industry 2025: Increasing Multiple Sclerosis Prev ...

Curatis Holding (SIX:CURN) announces today the formation of an Advisory Board comprised of four internationally recognized experts across multiple medical and scientific disciplines. The ...

Wendel, the listed holding company, long owned around 40% of the French testing and certification company, but has reduced ...

The Swiss pharma group has agreed to pay $800 million upfront for London, UK-based Gyroscope ... according to Novartis. The one-shot therapy aims to treat GA by delivering the gene for complement ...

Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong ...

Adding European shares for diversification could be the answer. The post Worried about US shares? Adding European shares ...